Device Biosurgical

Ethicon

Payments companies reported to CMS as associated with Ethicon. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.3Massociated payments (2023-2025)

5,696clinicians with associated payments

5companies reporting

By year

2023 $277K

2024 $413K

2025 $653K

Payments reported as associated with Ethicon, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $294K

Physician Assistant $271K

Gynecologic Oncology $123K

Surgical $111K

Obstetrics & Gynecology $106K

Surgery $71K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ethicon

These are the largest totals companies reported as associated with Ethicon. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Stephen Ingram	Austin, TX	Physician Assistant	$185,251.12
Faraz Kerendi	Austin, TX	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$143,289.49
Grayson Wheatley	Nashville, TN	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$131,696.89
Jonathan Black	Miramar, FL	Gynecologic Oncology	$110,093.20
Jeanine Gargiulo	Alexandria, VA	Surgical	$82,996.12
Matthew Varacallo	Du Bois, PA	Sports Medicine (Orthopaedic Surgery)	$39,615.00
Andrew Nunn	Winston Salem, NC	Surgical Critical Care	$38,336.57
Kurian Thott	Stafford, VA	Obstetrics & Gynecology	$37,602.43
Gitonga Munene	Kalamazoo, MI	Surgical Oncology	$35,788.41
Konstantin Slavin	Chicago, IL	Neurological Surgery	$21,587.50

Prescribed Ethicon?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.